Atlas Venture Life Science Advisors as of Dec. 31, 2024
Portfolio Holdings for Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors holds 13 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kymera Therapeutics Common Stock (KYMR) | 24.0 | $197M | 4.9M | 40.23 | |
| Dyne Therapeutics Common Stock (DYN) | 23.1 | $189M | 8.0M | 23.56 | |
| Disc Medicine Common Stock (IRON) | 19.4 | $159M | 2.5M | 63.40 | |
| Third Harmonic Bio Common Stock (THRD) | 13.1 | $107M | 10M | 10.29 | |
| Day One Biopharmaceuticals Common Stock (DAWN) | 9.9 | $82M | 6.4M | 12.67 | |
| Korro Bio Common Stock (KRRO) | 5.3 | $43M | 1.1M | 38.07 | |
| Vigil Neuroscience Common Stock (VIGL) | 1.2 | $9.9M | 5.8M | 1.70 | |
| Generation Bio Common Stock | 1.1 | $8.8M | 8.3M | 1.06 | |
| Ikena Oncology Common Stock (IKNA) | 1.0 | $8.2M | 5.0M | 1.64 | |
| Q32 Bio Common Stock (QTTB) | 0.9 | $7.2M | 2.1M | 3.44 | |
| Aerovate Therapeutics Common Stock (AVTE) | 0.6 | $4.8M | 1.8M | 2.65 | |
| Tectonic Therapeutics Common Stock (TECX) | 0.4 | $3.6M | 78k | 46.17 | |
| Spero Therapeutics Common Stock (SPRO) | 0.0 | $314k | 305k | 1.03 |
